SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIGOLIN, Gian Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.425
AS - Asia 13.021
EU - Europa 8.537
SA - Sud America 2.035
AF - Africa 266
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 11
AN - Antartide 1
Totale 45.328
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.904
SG - Singapore 4.873
CN - Cina 3.274
IT - Italia 2.410
BR - Brasile 1.561
VN - Vietnam 1.559
DE - Germania 1.380
UA - Ucraina 1.049
HK - Hong Kong 1.025
TR - Turchia 827
GB - Regno Unito 734
FR - Francia 667
FI - Finlandia 645
RU - Federazione Russa 365
SE - Svezia 360
JP - Giappone 356
PL - Polonia 260
IN - India 257
MX - Messico 229
CA - Canada 228
ID - Indonesia 185
NL - Olanda 181
AR - Argentina 175
BD - Bangladesh 160
ZA - Sudafrica 114
IQ - Iraq 90
BE - Belgio 84
ES - Italia 73
EC - Ecuador 70
CZ - Repubblica Ceca 67
CO - Colombia 61
PK - Pakistan 55
CL - Cile 52
UZ - Uzbekistan 51
LT - Lituania 45
AT - Austria 43
MY - Malesia 43
VE - Venezuela 42
SA - Arabia Saudita 37
AE - Emirati Arabi Uniti 35
PH - Filippine 33
IE - Irlanda 30
MA - Marocco 29
AU - Australia 26
PY - Paraguay 25
TN - Tunisia 25
KE - Kenya 21
DZ - Algeria 19
RO - Romania 19
AZ - Azerbaigian 18
EG - Egitto 18
PE - Perù 17
UY - Uruguay 17
CH - Svizzera 16
IL - Israele 15
BO - Bolivia 13
JO - Giordania 13
AL - Albania 12
DO - Repubblica Dominicana 12
IR - Iran 12
LV - Lettonia 12
ET - Etiopia 11
OM - Oman 10
HU - Ungheria 9
KR - Corea 9
KZ - Kazakistan 9
NP - Nepal 9
PT - Portogallo 9
RS - Serbia 9
YE - Yemen 9
DK - Danimarca 8
EU - Europa 8
JM - Giamaica 8
PA - Panama 8
PS - Palestinian Territory 8
SV - El Salvador 8
BY - Bielorussia 7
TH - Thailandia 7
HR - Croazia 6
SI - Slovenia 6
BG - Bulgaria 5
GR - Grecia 5
KG - Kirghizistan 5
LB - Libano 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
AO - Angola 4
GE - Georgia 4
GT - Guatemala 4
KW - Kuwait 4
MT - Malta 4
PR - Porto Rico 4
QA - Qatar 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
CG - Congo 3
CI - Costa d'Avorio 3
EE - Estonia 3
LY - Libia 3
Totale 45.267
Salva come PNG Salva come JPEG
Città #
Singapore 3.089
Ashburn 2.492
Woodbridge 1.778
Fairfield 1.673
San Jose 1.232
Houston 1.217
Beijing 1.148
Jacksonville 1.121
Chandler 1.098
Hong Kong 1.002
Santa Clara 954
Ann Arbor 790
Seattle 675
Wilmington 645
Cambridge 561
Ho Chi Minh City 473
Izmir 440
Los Angeles 398
New York 397
Nanjing 370
Dallas 359
Tokyo 339
Hanoi 335
Munich 310
Princeton 288
Helsinki 276
Ferrara 268
Milan 263
Lauterbourg 260
Council Bluffs 251
Warsaw 231
São Paulo 182
Shanghai 165
Boardman 160
San Diego 160
Mexico City 140
Jakarta 123
Rome 121
Turku 120
Nanchang 116
Orem 114
Shenyang 114
Dong Ket 108
Bremen 100
Addison 99
Buffalo 99
London 97
Chicago 86
Da Nang 82
Brussels 80
Tianjin 80
Montreal 77
Hefei 75
Hebei 70
Jiaxing 68
Haiphong 67
Toronto 67
Dearborn 62
Rio de Janeiro 62
Brooklyn 61
Changsha 61
Johannesburg 61
Chennai 59
Moscow 59
Denver 58
Frankfurt am Main 56
Bologna 55
Stockholm 51
Phoenix 49
Poplar 47
Jinan 46
Tashkent 46
Amsterdam 44
Falls Church 44
Manchester 44
Brno 42
Norwalk 41
Atlanta 40
Biên Hòa 39
Naples 39
San Francisco 39
Boston 38
Falkenstein 36
Redwood City 36
Zhengzhou 36
Bari 35
Guangzhou 34
Mountain View 34
Mumbai 34
San Mateo 34
The Dalles 33
Lappeenranta 32
Salt Lake City 32
Baghdad 31
Florence 31
Hải Dương 31
Parma 31
Brasília 29
Dublin 27
Verona 27
Totale 29.329
Salva come PNG Salva come JPEG
Nome #
Ripristino dell’apoptosi mediata da p53: ruolo degli inibitori di MDM2. 1.205
Fisiologia piastrinica. 322
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 313
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 286
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival 276
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 273
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 273
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 272
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 271
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 271
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 269
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 267
A case of disseminated Langerhans' cell histiocytosis treated with thalidomide 266
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 263
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 260
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 260
A case of advanced Hodgkin lymphoma with breast involvement treated with a combination of gemcitabine and pegylated liposomal doxorubicin. 259
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 258
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 258
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 256
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 250
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 250
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 248
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 247
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 247
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype 241
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 238
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 238
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 237
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 236
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 235
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 234
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 233
B-Cell chronic lymphocytic leukemia (B-CLL) with 14q32 translocations: haematological features and clinical outcome. 231
Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: Comparison with metaphase banding analysis 227
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells 226
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 226
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 226
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 225
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 223
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 222
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 221
Secondary chromosome changes in mantle cell lymphoma: Cytogenetic and fluorescence in situ hybridization studies 220
Exposure to myelotoxic agents and myelodysplasia: Case-control study and correlation with clinicobiological findings 220
A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients 218
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 218
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 218
Delirium in acute promyelocytic leukemia patients: Two case reports 218
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 216
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 216
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 215
Alterazioni cromosomiche in cellule staminali emopoietiche indotte da esposizioni ambientali o professionali. 214
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 214
Dendritic cells and vascular endothelial growth factor in colorectal cancer: Correlations with clinicobiological findings 214
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 213
A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes 212
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 212
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 212
Isolated thrombocytopenia by splenic sequestration in hemodialyzed patients 211
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 210
Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation 209
Differentiation of follicular dendritic sarcoma cells into functional myeloiddendritic cell-like elements 206
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 204
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia 203
Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation 203
Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients 202
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: Correlations with clinical and transplant characteristics 199
Abnormalities of chromosomes 1p34-36, 4p16, 4q35, 9q11-32 and +7 represent novel recurrent cytogenetic rearrangements in chronic lymphocytic leukemia 198
Cellule endoteliali progenitrici e grado di attività fisica in una popolazione di pazienti nefropatici emodializzati 197
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 196
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: Correlations with aetiological and clinical-biological findings 196
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome 196
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 195
Dendritic cells in acute promyelocytic leukaemia 194
Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features 193
A Molecular Model to Predict Durable Remission after First Line Fludarabine-Cyclophosphamide-Rituximab Treatment in Chronic Lymphocytic Leukemia 191
Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation 191
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 190
Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with granulocyte colony stimulating factor and chemotherapy for autologous transplantation 189
Hepatosplenic T-cell lymphoma (HSTCL). 189
Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biological significance 189
INTEGRATION OF NOVEL GENE MUTATIONS INTO KARYOTYPE-BASED SUBGROUPS AS A PROGNOSTIC RISK STRATIFICATION TOOL IN CHRONIC LYMPHOCYTIC LEUKEMIA 189
Mobilization of endothelial progenitor cells in patientes with haematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation 189
Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile 189
Multilineage involvement in the 5q- syndrome: A fluorescent in situ hybridization study on bone marrow smears 188
Grave colestasi di origine paraneoplastica in donna ultraottantenne con linfoma B-cellulare anaplastico misconosciuto [Severe paraneoplastic cholestasis in a octogenarian woman with unrecognized anaplastic B-cell lymphoma] 188
Exercise capacity and circulating endothelial progenitor cells in hemodialysis patients 187
Minimal morphological criteria for defining bone marrow dysplasia: A basis for clinical implementation of WHO classification of myelodysplastic syndromes 187
Hemophagocytic Lymphohistiocytosis in a Patient with Relapsed Chronic Lymphocytic Leukemia Treated with Ibrutinib 187
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 187
Exercise training and endothelial progenitor cells in haemodialysis patients 186
Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) 184
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 183
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia 180
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 177
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes 176
Intestinal T-cell lymphoma 176
Leucemia linfoblastica acuta. 175
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 175
Study of prognosis in acute myeloid leukemias (AML) by cluster analysis 175
Totale 23.018
Salva come PNG Salva come JPEG
Categoria #
all - tutte 199.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 29.012
Totale 228.120
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021933 0 0 0 0 0 0 0 0 0 0 575 358
2021/20222.856 207 338 119 141 217 146 156 164 96 243 255 774
2022/20232.771 334 144 108 304 459 371 128 273 380 25 164 81
2023/20241.610 138 155 76 50 99 244 74 98 38 50 114 474
2024/20256.513 182 174 543 283 814 579 206 302 1.005 799 834 792
2025/202617.548 1.652 908 1.525 2.474 2.643 1.244 2.088 1.097 1.788 2.110 19 0
Totale 45.814